Pulmonary aspiration occurs when stomach contents enter the lungs ... especially in patients undergoing surgeries where ...

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

糖皮质激素（GC）的药理作用及临床适应症广泛，因其强大的抗炎、平喘作用，在呼吸科常被用于 慢性阻塞性肺疾病 （ COPD ）、 哮喘 等疾病治疗。GC 可缓解患者的临床症状、改善肺功能，提高生活质量。

Chronic obstructive pulmonary disease is a serious, progressive illness that hits the homeless and underinsured the hardest.

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.

Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...

Cambridge Healthcare Innovations (CHI) has joined forces with Aptar Pharma in the US to commercialise the Science Park ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

So, the new label now warns that rare cases of pulmonary aspiration have been reported in patients taking GLP-1 medications ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening ...